Ecopipam Treatment of Self-Injurious Behavior in Subjects With Lesch-Nyhan Disease
Clinical trial NCT01751802 · TERMINATED
Trial details
- NCT number
- NCT01751802
- Sponsor
- Emalex Biosciences Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2013-12-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.